Out-of-pocket spending and financial burden among medicare beneficiaries with cancer

JAMA Oncology

Volumn 3, Issue 6, 2017, Pages 757-765

  Narang, Amol K ^a   Nicholas, Lauren Hersch ^a,b,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; COST OF ILLNESS; ECONOMICS; FEMALE; FINANCIAL MANAGEMENT; HEALTH CARE COST; HEALTH INSURANCE; HUMAN; INCOME; MALE; MEDICARE; NEOPLASMS; PROSPECTIVE STUDY; SOCIAL CLASS; STATISTICS AND NUMERICAL DATA; UNITED STATES;

AGED; COST OF ILLNESS; FEMALE; FINANCING, PERSONAL; HEALTH EXPENDITURES; HUMANS; INCOME; INSURANCE, HEALTH; MALE; MEDICARE; NEOPLASMS; PROSPECTIVE STUDIES; SOCIAL CLASS; UNITED STATES;

EID: 85025099377     PISSN: 23742437     EISSN: 23742445     Source Type: Journal    
DOI: 10.1001/jamaoncol.2016.4865     Document Type: Article

References (56)

1. Soni A. The five most costly conditions, 1996 and 2006: estimates for the US civilian noninstitutionalized population. https://meps.ahrq.gov/mepsweb/data-files/publications/st248/stat248.pdf. Updated July 2009. Accessed July 1, 2015.
2. Mariotto AB, Yabroff KR, Shao Y, Feuer E.J., Brown ML. Projections of the cost of cancer care in the United States: 2010-2020. J Natl Cancer Inst. 2011; 103(2):117-128.
3. American Cancer Society. Cancer facts and statistics. http://www.cancer.org/research/cancerfactsstatistics. Accessed October 23, 2016.
4. The Henry J Kaiser Family Foundation. Medicare chartbook, 2010. http://kff.org/medicare/report/medicare-chartbook-2010/. Updated October 30, 2010. Accessed July 1, 2015.
5. Ramsey S, Blough D, Kirchhoff A., et al. Washington state cancer patients found to be at greater risk for bankruptcy than people without a cancer diagnosis. Health Aff (Millwood). 2013; 32(6): 1143-1152.
6. Zafar SY, Peppercorn JM, Schrag D, et al The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient's experience. Oncologist. 2013; 18(4): 381-390.
7. The Henry J Kaiser Family Foundation. Toplines: national survey of households affected by cancer. http://kff.org/health-costs/poll-finding/toplines-national-survey-of-households-affected-by/. Published November 1, 2006. Accessed July 1, 2015.
8. Dusetzina SB, Winn AN, Abel G.A., Huskamp HA, Keating NL. Cost sharing and adherence to tyrosine kinase inhibitors for patients with chronic myeloid leukemia. J Clin Oncol. 2014; 32(4):306-311.
9. Neugut AI, Subar M, Wilde E.T., et al. Association between prescription co-payment amount and compliance with adjuvant hormonal therapy in women with early-stage breast cancer. J Clin Oncol. 2011; 29(18):2534-2542.
10. Kent EE, Forsythe LP, Yabroff K.R., et al. Are survivors who report cancer-related financial problems more likely to forgo or delay medical care? Cancer. 2013; 119(20):3710-3717.
11. Goldman DP, Joyce GF, Zheng Y. Prescription drug cost sharing: associations with medication and medical utilization and spending and health. JAMA. 2007; 298(1):61-69.
12. Kaisaeng N, Harpe SE, Carroll NV Out-of-pocket costs and oral cancer medication discontinuation in the elderly. J Manag Care Spec Pharm. 2014; 20(7): 669-675.
13. Thorpe KE, Howard D. Health insurance and spending among cancer patients. Health Aff (Millwood). 2003; W3(suppl):W3-189-W3-198.
14. Ubel PA, Abernethy AP, Zafar SY Full disclosure - out-of-pocket costs as side effects. N Engl J Med. 2013; 369(16):1484-1486.
15. de Souza J.A., Yap BJ, Hlubocky F.J., et al. The development of a financial toxicity patient-reported outcomein cancer: the COST measure. Cancer. 2014; 120(20):3245-3253.
16. Zafar SY, Abernethy AP Financial toxicity, part I: a new name foragrowing problem. Oncology (Williston Park). 2013; 27(2):80-81, 149.
17. Meropol NJ, Schrag D, Smith T.J., et al; American Society of Clinical Oncology. American Society of Clinical Oncology guidance statement: the cost of cancer care. J Clin Oncol. 2009; 27(23):3868-3874.
18. Khera N. Reporting and grading financial toxicity. J Clin Oncol. 2014; 32(29):3337-3338.
19. Schnipper LE, Davidson NE, Wollins D.S., et al; American Society of Clinical Oncology. American Society of Clinical Oncology statement: a conceptual framework to assess the value of cancer treatment options. J Clin Oncol. 2015; 33(23): 2563-2577.
20. Langa KM, Fendrick AM, Chernew M.E., Kabeto MU, Paisley KL, Hayman JA. Out-of-pocket health-care expenditures among older Americans with cancer. Value Health. 2004; 7(2):186-194.
21. Davidoff AJ, Erten M, Shaffer T., et al. Out-of-pocket health care expenditure burden for Medicare beneficiaries with cancer. Cancer. 2013; 119(6):1257-1265.
22. The Henry J Kaiser Family Foundation. Medicare Advantage. http://kff.org/medicare/fact-sheet/medicare-advantage. Updated May 11, 2016. Accessed July 1, 2016.
23. Kelley AS, McGarry K, Fahle S., Marshall SM, Du Q, Skinner JS. Out-of-pocket spending in the last five years of life. J Gen Intern Med. 2013; 28(2): 304-309.
24. Juster FT, Suzman R. An overview of the Health and Retirement Study. J Hum Resour. 1995; 30 (suppl):S7-S56. doi:10.2307/146277
25. Kelley AS, Langa KM, Smith A.K., et al. Leveraging the Health and Retirement Study to advance palliative care research. J Palliat Med. 2014; 17(5):506-511.
26. Health and Retirement Study. Sample sizes and response rates. http://hrsonline.isr.umich.edu/sitedocs/sampleresponse.pdf. Updated Spring 2011. Accessed July 1, 2015.
27. Kaye HS, Harrington C, La Plante MP. Long-term care: who gets it, who provides it, who pays, and how much? Health Aff (Millwood). 2010; 29(1):11-21.
28. Centers for Disease Control and Prevention. Leading causes of death. http://www.cdc.gov/nchs/fastats/leading-causes-of-death.htm. Updated October 7, 2016. Accessed October 20, 2016.
29. Bureau of Labor Statistics, US Department of Labor. Consumer price index. http://www.bls.gov/cpi/. Accessed July 1, 2015.
30. Chien S, Campbell N, Hayden O., et al. RAND HRS Data Documentation, Version N. Santa Monica, CA: RAND Center for the Study of Aging; 2014.
31. Goldman DP, Zissimopoulos J, Lu Y. Medical expenditure measures inthe Health and Retirement Study. Forum Health Econ Policy. 2011; 14(3):4.
32. Banthin JS, Bernard DM Changes in financial burdens for health care: national estimates for the population younger than 65 years, 1996 to 2003. JAMA. 2006; 296(22):2712-2719.
33. Bernard DS, Farr SL, Fang Z. National estimates of out-of-pocket health care expenditure burdens among nonelderly adults with cancer: 2001 to 2008. J Clin Oncol. 2011; 29(20):2821-2826.
34. Goldman DP, Zissimopoulos JM High out-of-pocket health care spending by the elderly. Health Aff (Millwood). 2003; 22(3):194-202.
35. Health and Retirement Study: a longitudinal study of health, retirement, and aging sponsored by the National Institute on Aging. http://hrsonline.isr.umich.edu/. Accessed July 1, 2015.
36. Yabroff KR, Lund J, Kepka D., Mariotto A. Economic burden of cancer in the United States: estimates, projections, and future research. Cancer Epidemiol Biomarkers Prev. 2011; 20(10):2006-2014.
37. Yabroff KR, Lamont EB, Mariotto A, et al Cost of care for elderly cancer patients in the United States. J Natl Cancer Inst. 2008; 100(9):630-641.
38. Brooks GA, Li L, Uno H., Hassett MJ, Landon BE, Schrag D. Acute hospital care is the chief driver of regional spending variation in Medicare patients with advanced cancer. Health Aff (Millwood). 2014; 33(10):1793-1800.
39. Brooks GA, Jacobson JO, Schrag D. Clinician perspectives on potentially avoidable hospitalizations in patients with cancer. JAMA Oncol. 2015; 1(1):109-110.
40. Brooks GA, Abrams TA, Meyerhardt J.A., et al. Identification of potentially avoidable hospitalizations in patients with GI cancer. J Clin Oncol. 2014; 32(6):496-503.
41. Dinan MA, Hirsch BR, Lyman GH Management of chemotherapy-induced neutropenia: measuring quality, cost, and value. J Natl Compr Canc Netw. 2015; 13(1):e1-e7.
42. Nathan H, Atoria CL, Bach P.B., Elkin EB. Hospital volume, complications, and cost of cancer surgery in the elderly. J Clin Oncol. 2015; 33(1):107-114.
43. Hughes BG, Jain VK, Brown T, et al Decreased hospital stay and significant cost savings after routine use of prophylactic gastrostomy for high-risk patients with head and neck cancer receiving chemoradiotherapy at a tertiary cancer institution. Head Neck. 2013; 35(3):436-442.
44. Kuntz G, Tozer JM, Snegosky J, Fox J., Neumann K. Michigan oncology medical home demonstration project: first-year results. J Oncol Pract. 2014; 10(5):294-297.
45. Sprandio JD. Oncology patient-centered medical home. J Oncol Pract. 2012; 8(3)(suppl): 47s-49s.
46. Sanghavi D, Samuels K, George M., et al. Case study: transforming cancer care at a community oncology practice. Healthc (Amst). 2015; 3(3): 160-168.
47. Newcomer LN, Gould B, Page R.D., Donelan SA, Perkins M. Changing physician incentives for affordable, quality cancer care: results of an episode payment model. J Oncol Pract. 2014; 10(5): 322-326.
48. Colla CH, Lewis VA, Gottlieb D.J., Fisher ES. Cancer spending and accountable care organizations: evidence from the Physician Group Practice demonstration. Healthc (Amst). 2013; 1(3-4):100-107.
49. Center for Medicare & Medicaid Services. Oncology Care Model. https://innovation.cms.gov/initiatives/Oncology-Care/. Updated October 11, 2016. Accessed October 20, 2016.
50. Medicare.gov. Your Medicare costs. https://www.medicare.gov/your-medicare-costs/. Accessed December1, 2015.
51. Congressional Budget Office, Congress of the United States. Reducing the deficit: spending and revenue options. https://www.cbo.gov/sites/default/files/cbofiles/ftpdocs/120xx/doc12085/03-10-reducingthedeficit.pdf. Published March 2011. Accessed July 1, 2015.
52. The National Commission on Fiscal Responsibility and Reform. The moment of truth. https://www.fiscalcommission.gov/sites/fiscalcommission.gov/files/documents/TheMomentofTruth12-1-2010.pdf. Updated November 10, 2010. Accessed July 1, 2015.
53. Moment of Truth Project. Modernizing the Medicare benefit: a closer look at reforming Medicare cost-sharing rules. http://momentoftruthproject.org/publications/modernizing-medicare-benefit-closer-look-reforming-medicare-cost-sharing-rules/. Published June 24, 2013. Accessed July 1, 2015.
54. Davis K, Schoen C, Guterman S. Medicare essential: an option to promote better care and curb spending growth. Health Aff (Millwood). 2013; 32(5):900-909.
55. Baugh CW, Schuur JD Observation care - high-value care or a cost-shifting loophole? N Engl J Med. 2013; 369(4):302-305.
56. Feng Z, Wright B, Mor V. Sharp rise in Medicare enrollees being held in hospitals for observation raises concerns about causes and consequences. Health Aff (Millwood). 2012; 31(6):1251-1259.